CANTATORE, FRANCESCO PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 14.722
EU - Europa 11.155
AS - Asia 8.134
SA - Sud America 1.378
AF - Africa 145
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 23
Totale 35.581
Nazione #
US - Stati Uniti d'America 14.520
CN - Cina 3.105
IE - Irlanda 3.084
SG - Singapore 2.621
UA - Ucraina 2.119
RU - Federazione Russa 1.790
SE - Svezia 1.375
BR - Brasile 1.135
HK - Hong Kong 844
FR - Francia 665
DE - Germania 546
IT - Italia 489
VN - Vietnam 472
FI - Finlandia 410
IN - India 304
TR - Turchia 295
GB - Regno Unito 277
BD - Bangladesh 143
CZ - Repubblica Ceca 118
CA - Canada 100
AR - Argentina 97
IQ - Iraq 63
MX - Messico 63
PL - Polonia 50
EC - Ecuador 47
NL - Olanda 45
AT - Austria 41
JP - Giappone 37
ZA - Sudafrica 37
ID - Indonesia 36
BE - Belgio 33
UZ - Uzbekistan 25
PK - Pakistan 23
ES - Italia 22
EG - Egitto 20
EU - Europa 19
VE - Venezuela 19
CO - Colombia 18
MA - Marocco 18
PH - Filippine 18
CL - Cile 17
JO - Giordania 16
PY - Paraguay 16
SA - Arabia Saudita 16
AZ - Azerbaigian 14
TN - Tunisia 14
AU - Australia 13
IR - Iran 13
KE - Kenya 13
LT - Lituania 13
PE - Perù 13
JM - Giamaica 10
RO - Romania 10
DZ - Algeria 9
NP - Nepal 9
NZ - Nuova Zelanda 9
UY - Uruguay 9
DK - Danimarca 8
PT - Portogallo 8
CH - Svizzera 7
IL - Israele 7
LB - Libano 7
CI - Costa d'Avorio 6
HR - Croazia 6
KZ - Kazakistan 6
NG - Nigeria 6
OM - Oman 6
PA - Panama 6
SN - Senegal 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
ET - Etiopia 5
HU - Ungheria 5
KG - Kirghizistan 5
MY - Malesia 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BO - Bolivia 4
LV - Lettonia 4
MD - Moldavia 4
PS - Palestinian Territory 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AO - Angola 3
BG - Bulgaria 3
CR - Costa Rica 3
GT - Guatemala 3
HN - Honduras 3
MN - Mongolia 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
Totale 35.547
Città #
Dublin 3.080
San Jose 2.406
Dallas 1.804
Jacksonville 1.423
Chandler 1.330
Singapore 1.216
Dearborn 985
Nyköping 880
Ashburn 876
Hong Kong 835
Nanjing 650
Beijing 620
Santa Clara 420
Lauterbourg 344
Wilmington 339
Princeton 324
Munich 278
San Mateo 224
Nanchang 210
Moscow 207
New York 186
The Dalles 186
Helsinki 175
Los Angeles 167
Ho Chi Minh City 165
Shenyang 148
Boardman 141
Ann Arbor 121
Hebei 113
Des Moines 107
Jiaxing 102
Brno 97
São Paulo 97
Tianjin 96
Kunming 91
Woodbridge 91
Hanoi 83
Changsha 75
Shanghai 71
Foggia 70
Guangzhou 53
Hangzhou 48
Zhengzhou 46
London 45
Frankfurt am Main 44
Chicago 43
Jinan 42
Orem 42
Nuremberg 41
Dong Ket 34
Milan 33
San Francisco 33
Hilden 32
Brooklyn 31
Ningbo 29
Baghdad 28
Norwalk 28
Tokyo 28
Brussels 27
Hillsboro 27
Seattle 27
Taizhou 27
Rio de Janeiro 26
Warsaw 26
Columbus 25
Lanzhou 25
Washington 25
Chennai 24
Curitiba 24
Stevenage 24
Toronto 24
Atlanta 23
Guayaquil 23
Turku 23
Montreal 22
Pune 22
Rome 21
Tashkent 21
Amsterdam 20
Assago 20
Auburn Hills 20
Changchun 20
Da Nang 20
Falkenstein 20
Haiphong 20
Hanover 20
Manchester 20
Boston 19
Hefei 19
Belo Horizonte 18
Council Bluffs 18
Xi'an 18
Brasília 17
Orange 17
Salvador 17
Stockholm 17
Bari 16
Mexico City 16
Naples 16
Redwood City 16
Totale 22.403
Nome #
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 548
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 479
Visceral fat dysfunctions in the rat social isolation model of psychosis 262
Primary versus systemic sclerosis-associated Raynaud’s phenomenon: relationship with clinical and environmental factors 216
A case of rhupus treated with filgotinib: A promising therapeutic perspective 198
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 192
25-Hydroxycholecalciferol in experimental osteoporosis 173
SUBSTANCE P AND VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS DERIVING FROM PATIENTS WITH SYSTEMIC SCLEROSIS 159
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 157
Chronic psychosocial stress impairs bone homeostasis: A study in the social isolation reared rat 156
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 153
Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells 151
Extra-skeletal effects of bisphosphonates. 150
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 146
Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. 146
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients? 144
Adult Scheuermann's disease as cause of mechanic dorsalgia 144
The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort 143
Normal serum concentrations of 1,25 dihydroxyvitamin D in osteoporosis 141
Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis 140
Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis 140
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 140
A case of chondrodysplasia.Dolichomelic spondylo-epiphyseal chondrodysplasia 138
Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: the different pathological mechanisms. 137
Pubic symphysis sclerosis in psoriatic arthritis. Case report. 134
SUBCLINICAL ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS IN ITALIAN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM MULTICENTER GIRRCS (GRUPPO ITALIANO DI RICERCA IN REUMATOLOGIA CLINICA E SPERIMENTALE) STUDY 134
Ulcerative colitis and systemic lupus erythematosus. Minerva Med 132
Clodronate inhibits angiogenesis in vitro and in vivo 131
Effects of anabolic steroids, salmon calcitonin and 25OH-D3 on rat bones 131
Corticosteroids, a review. 129
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 129
Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept. 129
A comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects 129
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 128
Linear bone densitometry by monochromatic photon absorptiometry. A study of a normal population in Apulia 128
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 127
Anti-TNF-α and risk of infections: the experience in one center. 127
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. 126
COUNSELLING ON FAMILY PLANNING AND CONTRACEPTION, AND PREGNANCY OUTCOME IN WOMEN WITH RHEUMATIC DISEASES: A NATIONAL SURVEY OF 398 PATIENT-REPORTED QUESTIONNAIRES FROM 24 RHEUMATOLOGY CENTERS 126
Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause 125
Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts 125
Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3 125
Extracellular Matrix modulates angiogenesis in physiological and pathological conditions 125
Multiprofessional and intrahospital experience for diagnosis and treatment of pulmonary arterial hypertension 124
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease. 124
Evaluation of mineral metabolism and bone turnover in osteoporotic females treated withphosphorus and salmon calcitonin 123
Role of altered osteoblastic expression of Dkk-1 in the pathogenesis of osteoarthritis and osteoporosis 123
Bisphosphonates: effects on osteoblast. 123
Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) 123
Beta-2 microglobulin in osteoarthrosis 122
Anomalies de la capillaroscopie périunguéale au cours de la fibrose pulmonaire associée à la sclérodermie systémique et au cours de la fibrose pulmonaire idiopathique 122
Post biliopancreatic by-pass arthritis dermatitis syndrome 121
Serum 25(OH)D3 in theApulian population (Southern Italy). Epidemiologic study 121
Bone effects of biologic drugs in rheumatoid arthritis. 121
RANKL/OPG Ratio and DKK-1 Expression in Primary Osteoblastic Cultures from Osteoarthritic and Osteoporotic Subjects 121
A sequential treatment of osteoporosis with anabolic steroids and salmon calcitonin 120
Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis 118
Comments on Addolorata Corrado et al. review “Extra-skeletal effects of bisphosphonates” 118
Echographic study of Tietze's syndrome. 117
Mitochondrial disease mimicking polymyositis: a case report 117
BIOLOGIC THERAPIES AND INFECTIONS IN THE DAILY PRACTICE: A STUDY ON HISTORICAL COHORT FROM 3 ITALIAN RHEUMATOLOGIC UNITS 117
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 116
In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment 116
AB0171 Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 116
IgA nephropathy in systemic lupus erythematosus. 115
Fascite eosinofila: entità clinica a se stante o variante clinica della sclerosi sistemica? 115
Effects of nandrolonedecanoate on plasma calcitonin, parathormone and vitamin D, in elderly women 115
Metabolic effects of zoledronate on primary human osteoblastic cell cultures 115
La coxalgia 115
Vitamin D and the immune system 114
Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches 114
Serum osteocalcin levels in normal humans of different sex and age. An epidemiological study. 114
Anabolic therapy of induced osteoporosisin beta-thalassaemia major: case report and literature review 114
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases 114
Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report 113
Systemic effects of Wnt signaling 113
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 113
Bisphosphonates and osteoarthritis 113
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 113
Monitoring biological action of rapamycin in renal transplantation. 112
Osteocytes: central conductors of bone biology in normal and pathological conditions 112
EFFECTS OF DIFFERENT ANTI TNF ALPHA TREATMENTS ON LIPID AND CARBOHYDRATE METABOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS 112
AB0225 Clinical outcomes of treatment with golimumab in seropositive and seronegative rheumatoid arthritis patients in real-life settings. data from italian register gisea 112
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 112
AB0253 BIOMARKERS OF CLINICAL RESPONSE TO IL6-R BLOCKADE IN DMARDS INCOMPLETE RESPONDERS (AR-BIOM TRIAL): IL23 AND BAFF AS BIOLOGICAL TARGETS, AND ALBUMIN AS BIOLOGICAL PREDICTOR 112
Adipokines and Chronic Rheumatic Diseases: from Inflammation to Bone Involvement 112
Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial 111
C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. 111
Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 111
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis. 111
Osteocalcin: Skeletal and extra-skeletal effects 111
Two-Years Survival of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis and Predictors Thereof in Real-Life Settings 111
Integrine expression on human osteoblasts in osteoarthritis 110
Effects of anabolic steroids, 1.25(OH)D3 and calcitonin on osteocalcin and calciotropic hormones 110
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 110
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 110
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 110
SERUM 25(OH) VITAMIN D LEVELS, BODY MASS COMPOSITION AND EXTENT OF SKIN SCLEROSIS IN SYSTEMIC SCLEROSIS PATIENTS 110
THU0145 Changes in bone metabolism and trabecular bone score in patients with early rheumatoid arthritis 110
AB1290 VITAMIN D AND PAIN SYNDROME IN BREAST CANCER PATIENTS TREATED WITH ADJUVANT LETROZOLE 110
Totale 13.556
Categoria #
all - tutte 199.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 199.902


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/20221.622 234 23 14 10 123 35 45 141 250 222 93 432
2022/20236.944 630 249 282 364 352 632 34 506 3.515 68 150 162
2023/20241.175 179 60 66 51 79 278 23 50 15 47 27 300
2024/20255.508 305 51 118 188 184 824 611 401 1.458 371 482 515
2025/202611.418 578 997 2.285 1.329 463 492 2.195 1.041 816 673 287 262
Totale 36.698